Asset Details
Do you wish to reserve the book?
A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma
Do you wish to request the book?
A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma
2019
Overview
Cutaneous melanoma (CM) is a life-threatening form of skin cancer. Prognostic biomarkers can reliably stratify patients at initial melanoma diagnosis according to risk, and may inform clinical decisions. Here, we performed a retrospective, cohort-based study analyzing genome-wide DNA methylation of 461 patients with CM from the TCGA database. Cox regression analyses were conducted to establish a four-DNA methylation signature that was significantly associated with the overall survival (OS) of patients with CM, and that was validated in an independent cohort. Corresponding Kaplan–Meier analysis displayed a distinct separation in OS. The ROC analysis confirmed that the predictive signature performed well. Notably, this signature exhibited much higher predictive accuracy in comparison with known biomarkers. This signature was significantly correlated with immune checkpoint blockade (ICB) immunotherapy-related signatures, and may have potential as a guide for measures of responsiveness to ICB immunotherapy.
Publisher
eLife Science Publications, Ltd,eLife Sciences Publications Ltd,eLife Sciences Publications, Ltd
Subject
/ Adult
/ Aged
/ Biomarkers, Tumor - genetics
/ Cancer
/ DNA
/ Female
/ Gene Expression Regulation, Neoplastic
/ Genomes
/ Genomics
/ Humans
/ Male
/ Melanoma
/ Melanoma, Cutaneous Malignant
/ Methods
/ Patients
/ Skin
/ Skin Neoplasms - epidemiology
/ Survival
